Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Taffy J. Williams.
Shock | 1994
Kirk Kazarian; Philip W. Perdue; William Lynch; Adam J. Dziki; Joseph Nevola; Che-Hung Lee; Isaac Hayward; Taffy J. Williams; William R. Law
The characteristics of two types of intraperitoneal (i.p.) soilage sepsis models, autologous fecal inoculum (FEC) and a pure culture of Escherichia coli (EC), were studied in 26 male Yucatan minipigs (20–30 kg). Early (1–4 h) and late (24–72 h) changes were different between the two groups. The EC group was characterized early by hypotension, low cardiac output, and increased systemic and pulmonary vascular resistances, along with leukopenia, hypoglycemia, lactacidemia, and elevated blood urea nitrogen. Of the pigs in the EC group that survived the early effects, there were few significant differences in physiological parameters, compared to control pigs, that would indicate ongoing pathological processes. In contrast, the FEC group pigs demonstrated early hypotension, but with increased cardiac output and reduced systemic vascular resistance. Other parameter changes were similar to those seen in the EC pigs, but to a lesser degree, with the exception of elevations in serum lactate dehydrogenase. Also in contrast to the EC group, most of the changes in the FEC group persisted in later days, and FEC pigs demonstrated leukocytosis. There were also greater elevations in circulating lipopolysaccharide (LPS) concentrations in the EC group that returned later to baseline levels. In the FEC group, there were persistently elevated LPS concentrations over 72 h. These observations suggest that pigs challenged with intraperitoneal E. coli demonstrated an initial acute peritonitis and damaging physiologic effects of high levels of circulating LPS. Survivors in this group improved and were physiologically stable after 24 h. Pigs that received i.p. autologous feces developed an early acute peritonitis phase with lower levels of circulating LPS, and later developed pronounced peritoneal reaction as demonstrated by multiple abdominal abscesses, pyogenic granuloma formation, and adhesions with physiological evidence of developing sepsis over 72 h. These observations indicate that i.p. EC models evoke a systemic response not unlike intravenous administration of LPS or EC, however, the FEC model produced a systemic response akin to a slower developing septic process.
Shock | 1994
Thomas M. McKenna; Joanne M. Clegg; Taffy J. Williams
Treatment of vascular tissue with lipopolysaccharide (LPS) in vitro induces hyporesponsiveness to contractile agonists. We investigated whether protein kinase C (PKC) transduces the LPS signal into contractile dysfunction. Rat aortic tissue was incubated .5–18 h with LPS (10 or 30 ng/mL) or α- and β-phorbol 12,13-dibutyrate (PDB, .1 or 1 μ), either alone or combined with cycloheximide (50 μ) or the kinase inhibitors sphingosine (20 μ), H7 (1-(5-isoquinolinylsulfonyl)-2-methyl piperazine, 25 μ), and HA1004 (N-(2-guanidinoethyl)-5-isoquinolinesulfonamide, 25 μ). LPS and β-PDB induced a sustained translocation of PKC activity from the cytosol to the membrane, an increased protein synthesis-dependent expression of nitric oxide synthase (NOS) activity, and an impaired contractility that could be partially reversed by treatment with the NOS inhibitor Nω-nitro-L-arginine methyl ester. Incubation with α-PDB, an inactive isomer of β-PDB, did not alter any of the tissue functions. Sphingosine blocked LPS- and β-PDB-induced NOS activity and LPS-induced impairments in tissue contractility and PKC translocation. Incubation with H7 also protected against LPS-induced vasoplegia, while HA1004, used as a negative control for H7, provided little protection against LPS. These data indicate that PKC plays a role as an intracellular mediator of LPS-induced NOS activity and vascular suppression.
Journal of Surgical Research | 1994
Lynne D. Hoban; Marissa Pierce; Jerry Quance; Isaac Hayward; Adam Mckee; D. Channe Gowda; Dan W. Urry; Taffy J. Williams
Journal of Surgical Research | 1993
Mark A. Fletcher; Thomas M. McKenna; Jerry Quance; Norman R. Wainwright; Taffy J. Williams
Journal of Surgical Research | 1994
Philip W. Perdue; Kirk Kazarian; Joseph Nevola; William R. Law; Taffy J. Williams
MRS Proceedings | 1992
Dan W. Urry; D. Channe Gowda; Betty A. Cox; Lynne D. Hoban; Adam Mckee; Taffy J. Williams
Archive | 1991
Thomas M. McKenna; Taffy J. Williams
Critical Care Medicine | 1990
J. Allan Paschall; Vinay Nadkarni; James B. Hermiller; Jon M. Eckstein; Lynne D. Hoban; Joseph Nevola; Taffy J. Williams
Shock | 1994
M. C. Falk; T. K. Morrison; W. M. Ching; Taffy J. Williams; T. M. McKenna
Archive | 1992
Mark A. Fletcher; Timothy K. Morrison; Taffy J. Williams